Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03621982
Title Study of ADCT-301 in Patients With Selected Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors ADC Therapeutics S.A.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | BEL

Facility Status City State Zip Country Details
Stanford Cancer Center Palo Alto California 94304 United States Details
Smilow Cancer Hospital Phase 1 Unit New Haven Connecticut 06511 United States Details
Oregon Health and Science University Portland Oregon 97239 United States Details
The Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
The START Center for Cancer Care San Antonio Texas 78229 United States Details
Institut Jules Bordet Anderlecht B-1070 Belgium Details
Universitair Ziekenhuis Gent Gent 9000 Belgium Details
University College London Hospitals NHS Foundation Trust London England NW1 2PG United Kingdom Details
The Christie NHS Foundation Trust Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field